MTCR
Price:
$0.4949
Market Cap:
$21.69M
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.[Read more]
Industry
Biotechnology
IPO Date
2020-09-16
Stock Exchange
NASDAQ
Ticker
MTCR
According to Metacrine, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.48. This represents a change of -30.07% compared to the average of -0.69 of the last 4 quarters.
The mean historical PE Ratio of Metacrine, Inc. over the last ten years is -4.72. The current -0.48 PE Ratio has changed 915.98% with respect to the historical average. Over the past ten years (40 quarters), MTCR's PE Ratio was at its highest in in the September 2020 quarter at -0.36. The PE Ratio was at its lowest in in the June 2020 quarter at -8.18.
Average
-4.72
Median
-4.88
Minimum
-8.68
Maximum
-0.46
Discovering the peaks and valleys of Metacrine, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.46
Minimum Annual Increase = -77.19%
Minimum Annual PE Ratio = -8.68
Year | PE Ratio | Change |
---|---|---|
2021 | -0.46 | -77.19% |
2020 | -2.03 | -73.68% |
2019 | -7.72 | -11.08% |
The current PE Ratio of Metacrine, Inc. (MTCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.41
5-year avg
-4.72
10-year avg
-4.72
Metacrine, Inc.’s PE Ratio is less than Magenta Therapeutics, Inc. (-0.04), greater than Protara Therapeutics, Inc. (-1.35), less than TRACON Pharmaceuticals, Inc. (0.02), greater than Satsuma Pharmaceuticals, Inc. (-0.77), greater than Neoleukin Therapeutics, Inc. (-0.98), less than CytomX Therapeutics, Inc. (7.73), greater than Assembly Biosciences, Inc. (-2.10), greater than Instil Bio, Inc. (-1.50), greater than Nuvation Bio Inc. (-1.10), less than Vaccinex, Inc. (-0.33), greater than Monopar Therapeutics Inc. (-8.34), greater than Miromatrix Medical Inc. (-3.41), greater than Surrozen, Inc. (-0.70), greater than Anebulo Pharmaceuticals, Inc. (-5.95), greater than ZIVO Bioscience, Inc. (-4.35), greater than Indaptus Therapeutics, Inc. (-0.63),
Company | PE Ratio | Market cap |
---|---|---|
-0.04 | $42.44M | |
-1.35 | $53.43M | |
0.02 | $136.30K | |
-0.77 | $36.47M | |
-0.98 | $8.20M | |
7.73 | $78.90M | |
-2.10 | $107.75M | |
-1.50 | $179.70M | |
-1.10 | $764.36M | |
-0.33 | $9.06M | |
-8.34 | $87.22M | |
-3.41 | $92.95M | |
-0.70 | $38.09M | |
-5.95 | $49.01M | |
-4.35 | $68.83M | |
-0.63 | $11.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Metacrine, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Metacrine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Metacrine, Inc.'s PE Ratio?
How is the PE Ratio calculated for Metacrine, Inc. (MTCR)?
What is the highest PE Ratio for Metacrine, Inc. (MTCR)?
What is the 3-year average PE Ratio for Metacrine, Inc. (MTCR)?
What is the 5-year average PE Ratio for Metacrine, Inc. (MTCR)?
How does the current PE Ratio for Metacrine, Inc. (MTCR) compare to its historical average?